Mesenchyma-suppressing therapy of chronically active hepatitis using D-penicillamine
Mörl, M.
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1387-1389
1975
ISSN/ISBN: 0070-4067 PMID: 1226974 Document Number: 85624
Document emailed within 1 workday
Related Documents
Junge, U.; Lubrich, E.; Schumann, E.; Hauswaldt, C.; Perings, E. 1974: The mesenchyma suppressing effect of D-penicillamine Verhandlungen der Deutschen Gesellschaft für Innere Medizin 80: 1407-1408Schnack, H. 1971: Therapy of active cirrhosis with penicillamine Wiener Medizinische Wochenschrift 121(49): 900-902
Heckers, H.; Gerhardt, H.; Leinweber, B.; Matthes, K.J. 1974: D-penicillamine therapy in chronic aggressive hepatitis Verhandlungen der Deutschen Gesellschaft für Innere Medizin 80: 506-510
Busse, H.J.; Nilius, R.; Otto, L.; Zipprich, B.; Eismann, R. 1973: Therapy of chronic aggressive hepatitis with D-penicillamine Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 28(12 Suppl): 178-180
Wegener, M.; Börsch, G.; Schmidt, G. 1986: Drug therapy of chronic active hepatitis Medizinische Klinik 81(6): 223-225
Terranova, R.; Luca, S. 1999: Different types of interferon for the therapy of HCV chronic active hepatitis in the elderly patient European Review for Medical and Pharmacological Sciences 3(2): 45-52
Bresci, G.; Parisi, G.; Banti, S.; Bertoni, M. 1993: Therapy of active chronic hepatitis with recombinant alpha 2b-interferon: an 18 month follow-up European Journal of Medicine 2(6): 349-352
Spiegel, R.J. 1988: Additional indications for interferon therapy: basal cell carcinoma, carcinoid, and chronic active hepatitis Seminars in Oncology 15(5 Suppl 5: 41-45
Gros, H.; Zwirner, K. 1974: Treatment of chronic aggressive hepatitis with D-Penicillamine Medizinische Klinik 69(8): 333-337
Shah, H.A.; Kayani, N.; Sheikh, H.; Jafri, S.W.; Hamid, S.; Khan, A.H. 1995: Comparison of liver histology in chronic active hepatitis C and chronic active hepatitis B Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 14(3): 91-94
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Villari, D.; Pernice, M.; Spinella, S.; Squadrito, G.; Rodinò, G.; Brancatelli, S.; Longo, G.; Raimondo, G. 1995: Chronic hepatitis in patients with active hepatitis B virus and hepatitis C virus combined infections: a histological study American Journal of Gastroenterology 90(6): 955-958
Pastore, L.; Fiore, J.R.; Tateo, M.; De Benedittis, M.; Petruzzi, M.; Casalino, C.; Genchi, C.; Lo Muzio, L.; Angarano, G.; Serpico, R. 2006: Detection of hepatitis C virus-RNA in saliva from chronically HCV-infected patients International Journal of Immunopathology and Pharmacology 19(1): 217-224
Oroszlán, G.; Sanderud, J.; Saugstad, O.D.; Lakatos, L. 1992: D-penicillamine: old drug, new indication? D-penicillamine reduced pulmonary hypertension induced by free radicals Orvosi Hetilap 133(44): 2835-2836; 2839
Hinoue, Y.; Unoura, M.; Kato, Y.; Kobayashi, K.; Hattori, N. 1984: Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(2): 205-211
Galanti, B.; Nardiello, S. 1984: Recent findings concerning the immunopathogenesis of chronic active hepatitis by hepatitis B virus La Ricerca in Clinica e in Laboratorio 14 Suppl. 2: 67-74
Sampliner, R. 1977: Chronic active hepatitis in hepatitis B surface antigen (HBsAg) carriers. the need for liver biopsy JAMA 237(1): 50-51
Nasonov, E.L.; Burlev, V.A.; Golosova, T.V.; Speranskiĭ, A.I.; Somova, A.V. 1977: Autoimmune component in chronic active hepatitis and its connection with isolation of the hepatitis B surface antigen Terapevticheskii Arkhiv 49(6): 84-89
McCarthy, M.C.; Burans, J.P.; Constantine, N.T.; el-Hag, A.A.; el-Tayeb, M.E.; el-Dabi, M.A.; Fahkry, J.G.; Woody, J.N.; Hyams, K.C. 1989: Hepatitis B and HIV in Sudan: a serosurvey for hepatitis B and human immunodeficiency virus antibodies among sexually active heterosexuals American Journal of Tropical Medicine and Hygiene 41(6): 726-731